Patrick Sheridan

3.8k total citations · 1 hit paper
13 papers, 1.8k citations indexed

About

Patrick Sheridan is a scholar working on Rheumatology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Patrick Sheridan has authored 13 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 4 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Patrick Sheridan's work include Folate and B Vitamins Research (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Esophageal and GI Pathology (3 papers). Patrick Sheridan is often cited by papers focused on Folate and B Vitamins Research (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Esophageal and GI Pathology (3 papers). Patrick Sheridan collaborates with scholars based in Canada, United States and Australia. Patrick Sheridan's co-authors include Salim Yusuf, Hertzel C. Gerstein, Viswanathan Mohan, Bernard Zinman, Jackie Bosch, J.E. Shaw, Janice Pogue, M Hanefeld, Markku Laakso and Eva Lonn and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Patrick Sheridan

13 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

2006 1.2k citations Hertzel C. Gerstein, Salim Yusuf et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Sheridan Canada	12	1.0k	628	303	282	275	13	1.8k
M. G. Wulffelé Netherlands	9	964 1.0×	689 1.1×	336 1.1×	136 0.5×	352 1.3×	11	1.7k
D. Bets Netherlands	7	767 0.8×	544 0.9×	267 0.9×	103 0.4×	346 1.3×	9	1.4k
Gary Ko Hong Kong	23	559 0.6×	390 0.6×	265 0.9×	262 0.9×	144 0.5×	51	1.6k
J. de Jager Netherlands	6	630 0.6×	460 0.7×	216 0.7×	142 0.5×	229 0.8×	10	1.2k
Gerjan Navis Netherlands	26	586 0.6×	315 0.5×	303 1.0×	438 1.6×	110 0.4×	79	2.5k
Mari-Anne Gall Denmark	17	797 0.8×	253 0.4×	304 1.0×	725 2.6×	115 0.4×	26	2.1k
Andreas Tomaschitz Austria	33	873 0.9×	452 0.7×	554 1.8×	859 3.0×	113 0.4×	80	2.9k
Olga Scherbakova United Kingdom	4	997 1.0×	290 0.5×	528 1.7×	522 1.9×	406 1.5×	4	2.2k
Philip J. Klemmer United States	19	636 0.6×	292 0.5×	284 0.9×	594 2.1×	84 0.3×	38	1.9k
Soledad García de Vinuesa Spain	22	391 0.4×	384 0.6×	718 2.4×	620 2.2×	215 0.8×	53	2.8k

Countries citing papers authored by Patrick Sheridan

Since Specialization

Citations

This map shows the geographic impact of Patrick Sheridan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Sheridan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Sheridan more than expected).

Fields of papers citing papers by Patrick Sheridan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Sheridan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Sheridan. The network helps show where Patrick Sheridan may publish in the future.

Co-authorship network of co-authors of Patrick Sheridan

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Sheridan. A scholar is included among the top collaborators of Patrick Sheridan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Sheridan. Patrick Sheridan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Sheridan, Patrick, et al.. (2022). Sanitation Criteria: A Comprehensive Review of Existing Sustainability and Resilience Evaluation Criteria for Sanitation Systems. Environmental Science & Technology Letters. 9(7). 583–591. 7 indexed citations

Butcher, Kenneth, Kelvin Ng, Patrick Sheridan, et al.. (2020). Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke. Stroke. 51(4). 1190–1198. 28 indexed citations

Sheridan, Patrick, et al.. (2016). Analysis of Caffeine in Beverages Using Aspirin as a Fluorescent Chemosensor. Journal of Chemical Education. 93(10). 1776–1780. 15 indexed citations

Boyko, Edward J., Hertzel C. Gerstein, Viswanathan Mohan, et al.. (2010). Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetic Medicine. 27(11). 1226–1232. 14 indexed citations

Lonn, Eva, Hertzel C. Gerstein, Patrick Sheridan, et al.. (2009). Effect of Ramipril and of Rosiglitazone on Carotid Intima-Media Thickness in People With Impaired Glucose Tolerance or Impaired Fasting Glucose. Journal of the American College of Cardiology. 53(22). 2028–2035. 44 indexed citations

Saposnik, Gustavo, et al.. (2009). Homocysteine-Lowering Therapy and Stroke Risk, Severity, and Disability. Stroke. 40(4). 1365–1372. 200 indexed citations

Hanley, Anthony J., et al.. (2009). Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose. Diabetes Care. 33(3). 608–613. 38 indexed citations

Held, Claes, Glen Sumner, Patrick Sheridan, et al.. (2008). Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART). Vascular Medicine. 13(4). 245–253. 31 indexed citations

McDonald, Sarah D., et al.. (2008). Dysglycemia and a History of Reproductive Risk Factors. Diabetes Care. 31(8). 1635–1638. 21 indexed citations

10.

Mann, Johannes F.E., Patrick Sheridan, Matthew McQueen, et al.. (2007). Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study. Nephrology Dialysis Transplantation. 23(2). 645–653. 72 indexed citations

11.

Ray, Joel G., et al.. (2007). Venous thromboembolism in association with features of the metabolic syndrome. QJM. 100(11). 679–684. 29 indexed citations

12.

Ray, Joel G., et al.. (2007). Homocysteine-Lowering Therapy and Risk for Venous Thromboembolism. Annals of Internal Medicine. 146(11). 761–767. 92 indexed citations

13.

Gerstein, Hertzel C., Salim Yusuf, Jackie Bosch, et al.. (2006). Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. The Lancet. 368(9541). 1096–1105. 1213 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact